These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 28867456)

  • 1. Antimicrobial activity of bitespiramycin, a new genetically engineered macrolide.
    He W; Yang C; Zhao X; Wang Y
    Bioorg Med Chem Lett; 2017 Oct; 27(19):4576-4577. PubMed ID: 28867456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro activity of azithromycin against Chlamydia trachomatis, Ureaplasma urealyticum and Mycoplasma hominis in comparison with erythromycin, roxithromycin and minocycline.
    Rumpianesi F; Morandotti G; Sperning R; Satta G; Cevenini R
    J Chemother; 1993 Jun; 5(3):155-8. PubMed ID: 8396626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro activity of CEM-101, a new fluoroketolide antibiotic, against Chlamydia trachomatis and Chlamydia (Chlamydophila) pneumoniae.
    Roblin PM; Kohlhoff SA; Parker C; Hammerschlag MR
    Antimicrob Agents Chemother; 2010 Mar; 54(3):1358-9. PubMed ID: 20038627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activity of nemonoxacin, a novel nonfluorinated quinolone antibiotic, against Chlamydia trachomatis and Chlamydia pneumoniae.
    Chotikanatis K; Kohlhoff SA; Hammerschlag MR
    Antimicrob Agents Chemother; 2014; 58(3):1800-1. PubMed ID: 24366753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activity of midecamycin diacetate against Mycoplasma pneumoniae and Chlamydia pneumoniae.
    Pereyre S; de Barbeyrac B; Renaudin H; Poutiers F; Bébéar C; Bébéar CM
    J Antimicrob Chemother; 2001 Feb; 47(2):240-1. PubMed ID: 11157917
    [No Abstract]   [Full Text] [Related]  

  • 6. [Analysis of the infection status and the drug resistance of mycoplasma and chlamydiae in genitourinary tracts of children with suspected nongonococcal urethritis].
    Wang Y; Yang WB; Yuan HY; Zhang QX; Zhu XY
    Zhonghua Er Ke Za Zhi; 2009 Jan; 47(1):62-4. PubMed ID: 19573386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activity of a novel diaminopyrimidine compound, iclaprim, against Chlamydia trachomatis and C. pneumoniae.
    Kohlhoff SA; Roblin PM; Reznik T; Hawser S; Islam K; Hammerschlag MR
    Antimicrob Agents Chemother; 2004 May; 48(5):1885-6. PubMed ID: 15105151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Detection and the antibiotic susceptibility analysis of mycoplasma and chlamydia in urogenital tract infections of 327 cases patients with tubal infertility].
    Zhou Y; Xu XL; Wang CP; Zhou M; Zeng XH
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2011 Jun; 25(3):201-4. PubMed ID: 21977592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activity of AZD0914, a novel DNA gyrase inhibitor, against Chlamydia trachomatis and Chlamydia pneumoniae.
    Kohlhoff SA; Huband MD; Hammerschlag MR
    Antimicrob Agents Chemother; 2014 Dec; 58(12):7595-6. PubMed ID: 25288086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro activity of GAR-936 against Chlamydia pneumoniae and Chlamydia trachomatis.
    Roblin PM; Hammerschlag MR
    Int J Antimicrob Agents; 2000 Sep; 16(1):61-3. PubMed ID: 11185415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [In vitro, activity of a new macrolide (RU 28965) against Chlamydia trachomatis and Ureaplasma urealyticum].
    Sambri V; Rumpianesi F; Franchi L; Cevenini R
    G Ital Chemioter; 1985; 32(1):175-6. PubMed ID: 3830774
    [No Abstract]   [Full Text] [Related]  

  • 12. In vitro activities of rifamycin derivatives ABI-1648 (Rifalazil, KRM-1648), ABI-1657, and ABI-1131 against Chlamydia trachomatis and recent clinical isolates of Chlamydia pneumoniae.
    Roblin PM; Reznik T; Kutlin A; Hammerschlag MR
    Antimicrob Agents Chemother; 2003 Mar; 47(3):1135-6. PubMed ID: 12604555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [In vitro activity of sparfloxacin against mycoplasmas].
    Renaudin H; Bebear C
    Pathol Biol (Paris); 1992 May; 40(5):450-4. PubMed ID: 1323094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activity of azithromycin (CP-62,993) against Chlamydia trachomatis and Chlamydia pneumoniae.
    Agacfidan A; Moncada J; Schachter J
    Antimicrob Agents Chemother; 1993 Sep; 37(9):1746-8. PubMed ID: 8239579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro comparison of the activity of doxycycline, tetracycline, erythromycin and a new macrolide, CP 62993, against Mycoplasma pneumoniae, Mycoplasma hominis and Ureaplasma urealyticum.
    Rylander M; Hallander HO
    Scand J Infect Dis Suppl; 1988; 53():12-7. PubMed ID: 2843982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and treatment of Chlamydia trachomatis, Ureaplasma urealyticum, and Mycoplasma hominis in patients with non-gonococcal urethritis.
    Kilic D; Basar MM; Kaygusuz S; Yilmaz E; Basar H; Batislam E
    Jpn J Infect Dis; 2004 Feb; 57(1):17-20. PubMed ID: 14985631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The demographic and behavioural profile of women with cervicitis infected with Chlamydia trachomatis, Mycoplasma hominis and Ureaplasma urealyticum and the comparison of two medical regimens.
    Guven MA; Gunyeli I; Dogan M; Ciragil P; Bakaris S; Gul M
    Arch Gynecol Obstet; 2005 Sep; 272(3):197-200. PubMed ID: 15778862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity of ciprofloxacin against Chlamydia trachomatis and Ureaplasma urealyticum.
    Rumpianesi F; Sambri V; Bertini S; Tamba I; Cevenini R
    Chemioterapia; 1984 Jun; 3(3):173-4. PubMed ID: 6529772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and antimicrobial susceptibility of Ureaplasma urealyticum and Mycoplasma hominis in female outpatients, 2009-2013.
    Wang QY; Li RH; Zheng LQ; Shang XH
    J Microbiol Immunol Infect; 2016 Jun; 49(3):359-62. PubMed ID: 25081985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The activity of miokamycin (MOM) against Chlamydia trachomatis and mycoplasmas in vitro.
    Ridgway GL; Mumtaz G; Gabriel G; Oriel JD
    J Antimicrob Chemother; 1983 Nov; 12(5):511-4. PubMed ID: 6608516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.